YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and ...

The project, titled Liver Immunocompetent Volumetric Engineering (LIVE), aims to address the shortage of donor organs by ...

Mitochondrial dysfunction is associated with various chronic diseases and cancers, including neurodegenerative diseases and ...

Technological innovation, strategic public–private collaborations, and accelerating adoption in life sciences position 3D ...

Gordian Bio, a biotechnology company pioneering large-scale in vivo functional genomics to unlock validated drug targets for ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

The mystery of early embryonic communication is starting to be unraveled thanks to a new stem cell-based model.

Global 3D Bioprinting Market OverviewThe global 3D bioprinting market is poised for strong growth, with projections ...

Researchers at the Centre for Heart Lung Innovation (HLI), St. Paul’s Hospital, developed an in-house 3D printer that produces living human heart tissue from patient-derived stem cells. This enables ...

Scientific Longevity Company Collaborates with Major Academic Institutions to Remove Tumor Defense Mechanisms and Help Defeat Cancer in a Non-Toxic Manner MIAMI, Dec. 4, 2025 /PRNewswire/ -- Immorta ...

Located in the middle of the South Pacific, thousands of miles from the nearest continent, Easter Island (Rapa Nui) is one of the most remote inhabited places on Earth. To visit it and marvel at the ...

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers. Down the line, Adagene could make up to $840 million in development and commercial ...